Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4281918
Max Phase: Preclinical
Molecular Formula: C24H29N3O4
Molecular Weight: 423.51
Molecule Type: Small molecule
Associated Items:
ID: ALA4281918
Max Phase: Preclinical
Molecular Formula: C24H29N3O4
Molecular Weight: 423.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(C(=O)N(CC(=O)NC2CCCCC2)Cc2ccc(C(=O)NO)cc2)cc1
Standard InChI: InChI=1S/C24H29N3O4/c1-17-7-11-20(12-8-17)24(30)27(16-22(28)25-21-5-3-2-4-6-21)15-18-9-13-19(14-10-18)23(29)26-31/h7-14,21,31H,2-6,15-16H2,1H3,(H,25,28)(H,26,29)
Standard InChI Key: ZQJQUQLAPMMZQH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 423.51 | Molecular Weight (Monoisotopic): 423.2158 | AlogP: 3.21 | #Rotatable Bonds: 7 |
Polar Surface Area: 98.74 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.05 | CX Basic pKa: | CX LogP: 3.05 | CX LogD: 3.04 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.47 | Np Likeness Score: -1.38 |
1. Diedrich D, Stenzel K, Hesping E, Antonova-Koch Y, Gebru T, Duffy S, Fisher G, Schöler A, Meister S, Kurz T, Avery VM, Winzeler EA, Held J, Andrews KT, Hansen FK.. (2018) One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites., 158 [PMID:30245402] [10.1016/j.ejmech.2018.09.018] |
Source(1):